Therapeutic approach to chronic venous insufficiency and its complications: Place of Daflon® 500 mg

Angiology

Volumn 52, Issue 8 SUPPL. 1, 2001, Pages

  Bergan, J J ^a   Schmid Schonbein G W ^a   Takase, S ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD68 ANTIGEN; CELL ADHESION MOLECULE; CYTOKINE; DAFLON; TRANSFORMING GROWTH FACTOR BETA; BRADYKININ; CD11B ANTIGEN; FREE RADICAL; L SELECTIN; PROSTAGLANDIN; TRANSFORMING GROWTH FACTOR BETA1;

CELL DEATH; CELL MIGRATION; CHRONIC VEIN INSUFFICIENCY; CLINICAL FEATURE; CYTOKINE RELEASE; DRUG MECHANISM; HUMAN; HYPERTENSION; INFLAMMATION; LEUKOCYTE ACTIVATION; LEUKOCYTE ADHERENCE; MICROANGIOPATHY; PROTEIN EXPRESSION; REVIEW; SHEAR STRESS; SKIN ULCER; TREATMENT OUTCOME; TREATMENT PLANNING; VASCULAR ENDOTHELIUM; VEIN SURGERY; VENOUS PRESSURE; ARTICLE; COMPRESSION THERAPY; EDEMA; HYPERPIGMENTATION; LIPODERMATOSCLEROSIS; NONHUMAN; SURGICAL TECHNIQUE; ULCER HEALING;

EID: 0034889731     PISSN: 00033197     EISSN: None     Source Type: Journal    
DOI: 10.1177/0003319701052001s06     Document Type: Review

References (19)

1. Socioeconomic impact of chronic venous insufficiency: An underestimated public health problem
2. Leukocytes in chronic venous insufficiency
3. The postthrombotic syndrome in relation to venous hemodynamics as measured by means of duplex scanning and strain-gauge plethysmography
4. Leukocyte activation in patients with venous insufficiency
5. Expression of adhesion molecules and cytokines on saphenous veins in chronic venous insufficiency
6. The leukocyte response to fluid stress
7. Proximal long saphenous vein valves in primary venous insufficiency
8. A study of valve incompetence that developed in an experimental model of venous hypertension
9. Pathologie vasculaire et activation cellulaire
10. Cutaneous inflammation limited to the region of the ulcer in chronic venous insufficiency
11. 1 gene expression and protein production
12. Chronic inflammation: General mechanisms, with special attention for adhesion molecules and T-helper-1/T-helper-2 concept
13. Three treatments for chronic venous insufficiency: Escin, hydroxyethylrutoside, and Daflon® mg
14. Oral administration of purified micronized flavonoid fraction suppresses leukocyte adhesion in ischemia-reperfusion injury: In vivo observations in the hamster skinfold
15. Post-ischemic leukocyte/endothelial cell interactions and microvascular barrier disruption in skeletal muscle: Cellular mechanisms and effect of Daflon® 500 mg
16. Effect of oral micronized purified flavonoid fraction treatment on leukocyte adhesion molecule expression in patients with chronic venous insufficiency: A pilot study
17. Efficacy of Daflon 500 mg in venous leg ulcer healing: A double-blind, randomized, controlled versus placebo trial in 107 patients
18. The beneficial augmentative effect of micronized purified flavonoid fraction (MPFF) on the healing of leg ulcers: An open, multicenter, controlled, randomised study